SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001193125-19-032969
Filing Date
2019-02-11
Accepted
2019-02-11 06:45:32
Documents
2
Group Members
BIOVECTRA INC.

Document Format Files

Seq Description Document Type Size
1 SC 13G d656813dsc13g.htm SC 13G 63529
2 EXHIBIT 1 d656813dex991.htm EX-99.1 4072
  Complete submission text file 0001193125-19-032969.txt   69436
Mailing Address 3 LOTUS PARK, THE CAUSEWAY STAINES-UPON-THAMES SURREY X0 TW18 3AG
Business Address 3 LOTUS PARK, THE CAUSEWAY STAINES-UPON-THAMES SURREY X0 TW18 3AG 44-017-8463-6700
Mallinckrodt plc (Filed by) CIK: 0001567892 (see all company filings)

IRS No.: 981088325 | Fiscal Year End: 1228
Type: SC 13G
SIC: 2834 Pharmaceutical Preparations

Mailing Address 14405 WALTERS ROAD SUITE 780 HOUSTON TX 77014
Business Address 14405 WALTERS ROAD SUITE 780 HOUSTON TX 77014 281-402-3167
Oncolix, Inc. (Subject) CIK: 0001584137 (see all company filings)

IRS No.: 463046340 | State of Incorp.: FL | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-89187 | Film No.: 19581792
SIC: 2834 Pharmaceutical Preparations